Electric car maker Tesla CEO Elon ? Elon Musk has confirmed that the company is currently developing a third-generation vaccine printer for German vaccine company CureVac, which he believes will be ? a very important product for the world ?
Earlier this year, Musk announced that Tesla had become a manufacturing partner for German vaccine company CureVac, which is developing a new coronavirus vaccine based on RNA technology.
Musk had previously announced that Tesla would ? build an RNA microfactory for Germany-based CureVac?
The news came as a surprise because producing vaccine equipment is nothing like electric car manufacturing or renewable energy. Tesla has reportedly been working with CureVac since last year. The two companies ****together on a potentially revolutionary ?RNA bioreactor? for a potentially revolutionary RNA bioreactor.
Tesla will build automated systems for RNA printing and deploy them around the world, and CureVac claims to have found a way to stabilize RNA and deliver information to the body to fight specific diseases.
The company had previously worked on treating other flu strains, but shifted its focus to fighting the new coronavirus during the outbreak, and recently entered phase 2 clinical trials.
Musk visited Germany this past August, after reviewing the program with Curevac. Not long ago, Musk traveled to Germany again and responded on Twitter by saying, ? Tesla has already built an RNA bioreactor for making vaccines.CureVac is currently using version 2, and version 3 is in development...?
Musk added that he believes the product will be important to the world, but he doesn't think it will have a financial impact on Tesla: ? I do hope this product will be important to the world, but it probably won't be financially beneficial to Tesla.?
The idea of the two companies is that while CureVac is working on the vaccine, it also needs a way to manufacture and distribute it on a large scale. If the project is successful, Tesla will be credited with building the vaccine-producing ? microfactory ? and be rewarded. But Musk said investors should not take that into account.
In fact, this ? vaccine printer? doesn't have much to do with the start of the new crown, a collaboration between Musk and medical companies that began before the outbreak. But according to the narrative, the ? RNA bioreactor? should be using a common principle, meaning that virus-based vaccines can all use this feature to? print? vaccines in bulk.
It's worth enjoying what would happen if the new crown vaccine was available? The article doesn't mention when the technology will be ready for mass production, use around the world, etc. It's probably still in the development stage and impossible to predict. The New Crown vaccine has been gaining momentum and popping up more and more, mass production and global distribution is the next question. I do not know how this black technology mentioned constraints on the production conditions, if the constraints are low means that the vaccine can be produced in poor conditions in the region, the real benefit of low-income areas of the population, but also help to make a lot of experts headache of the vaccine distribution, storage and preservation of the dilemma. Musk words also seems to mean that it will make ? Vaccine printer? Pay the public good, benefit society.Musk is a typical representative of the United States of America's personal heroism and, there is always a dream to save all of mankind. Many people earlier thought he was a madman full of pie-in-the-sky stories, but SpaceX really did end up launching successfully at a very low cost, so maybe he can really do it.
We'd like to take a peek at Musk's life sometime soon, but I think he's a bit of a Frankenstein, whether it's his SpaceX Mars program or his Neutralink brain-computer interface technology, which feels like a sci-fi movie where he's shuttling around in mysterious, strange, alien labs every day.